It is also owned by Takeda and is administered once daily .
Alogliptin ( Nesina ) is the other major DPP - 4 inhibitor on the market .
Alogliptin is also owned by Takeda and is administered once daily .
Alogliptin ( Nesina ) is the other major DPP - 4 inhibitor on the market .